Daily as of 2 Nov 16:00 ET
- Price
- between the two $8.80 vs 50 $11.89 / 200 $7.72
- Projection
- No cross projected
- Test
- No active test
- Last cross
- No cross on record
Helus Pharma (HELP) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2026.
The 50 SMA sits above the 200 on the daily. The 200-day average is 9 sessions old; Cruxta projects nothing until it has 30. Price sits between the 50 and the 200 on the daily and below both on the 4-hour.
No weekly data
No 50/200 cross on record for HELP yet.
Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.